Arq. Bras. Oftalmol. 2023; 86 (4): 10.5935/0004-2749.2023-1004
Total: 1848
Tiago Santos Prata1,2,3 ; Fabio Bernardi Daga1 ; Ticiana De Francesco4; Iqbal Ike K. Ahmed5,6
DOI: 10.5935/0004-2749.2023-1004
1. Department of Ophthalmology, Universidade Federal de São Paulo, São Paulo, SP, Brazil
2. Department of Ophthalmology, Mayo Clinic, Jacksonville, Florida, USA
3. Glaucoma Sector, HMO, Opty Group, Brazil
4. Hospital de Olhos Leiria de Andrade, Fortaleza, CE, Brazil
5. University of Toronto, Toronto, Ontario, Canada
6. John Moran Eye Center, University of Utah, Salt Lake City, USA
Tiago S. Prata
E-mail: [email protected]
Funding: This study received no specific financial support.
Disclosure of potential conflicts of interest: TSP: Allergan, New World Medical; TDF: Allergan, Eilos Vision, Sight Sciences; IIKA: Alcon, Allergan, Eilos Vision, Glaukos, MST Surgical, New World Medical, Nova Eye, Sight Sciences; FBD: None.
How to cite this article:
ABO is licensed under a Creative Commons Attribution-NonComercial 4.0 Internacional.
